PHI with type 2 diabetes mellitus
How does this condition affect your private health insurance?
Diabetes mellitus Type 2 is a chronic metabolic disorder characterized by high blood sugar levels resulting from insulin resistance and relative insulin deficiency. Initially, the body's cells don't respond effectively to insulin, a hormone that regulates glucose uptake. Over time, the pancreas may reduce insulin production. It's often associated with lifestyle factors like obesity, physical inactivity, and genetics. Symptoms develop gradually and can include increased thirst, frequent urination, blurred vision, and fatigue. Untreated, it leads to severe complications affecting the heart, kidneys, eyes, and nerves.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Often insidious, with symptoms developing over weeks to months; diagnosis is typically made at a single point.
Duration of Illness (Lifetime)
Chronic, lifelong condition requiring ongoing management.
Cost of Treatment (Initial)
Initial diagnosis and management can range from a few hundred to several thousand USD, depending on immediate needs and healthcare system.
Cost of Treatment (Lifetime)
Significant; tens of thousands to hundreds of thousands of USD over a lifetime, including medications, monitoring, specialist visits, and complication management.
Mortality Rate
Not directly from the disease itself, but significantly increases the risk of premature death due to cardiovascular complications, kidney failure, and other severe health issues.
Risk of Secondary Damages
High, including cardiovascular disease (heart attack, stroke), nephropathy (kidney damage), retinopathy (eye damage leading to blindness), neuropathy (nerve damage), and foot problems.
Probability of Full Recovery
Low; while remission is possible with significant lifestyle changes (e.g., substantial weight loss), especially early on, it is generally considered a chronic, progressive disease requiring ongoing management and monitoring.
Underlying Disease Risk
High; frequently co-occurs with obesity, hypertension (high blood pressure), dyslipidemia (abnormal cholesterol levels), and metabolic syndrome.